Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01364740 · ClinicalTrials.gov registry record · Phase 3
PMP-300E (Smart Watch): Portable Monitoring Device Study
A Phase 3 study of Obstructive Sleep Apnea, sponsored by Stanford University.
- Completed
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT01364740 is a Phase 3 study of Obstructive Sleep Apnea that has completed, run by Stanford University. The registered enrollment target is 10 participants, below the 222-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01364740, a Phase 3 study of Obstructive Sleep Apnea, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
Validation of Portable Monitoring Device PMP-300E for Identification of Obstructive Sleep Apnea.
Conditions Studied
Interventions
- DEVICE PMP-300E
- DEVICE In-lab PSG
Study Locations (2)
California
- Center for Human Sleep Research - Redwood City
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-06 |
| Est. Completion | 2012-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01364740
The ClinicalTrials.gov registry entry for NCT01364740 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 222-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (95% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which PMP-300E is the first listed.
NCT01364740 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01364740 about?
NCT01364740 is a clinical study titled "PMP-300E (Smart Watch): Portable Monitoring Device Study". Validation of Portable Monitoring Device PMP-300E for Identification of Obstructive Sleep Apnea.
What is the current status of trial NCT01364740?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2008-06. Estimated completion is 2012-06.
What conditions does trial NCT01364740 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea.
What interventions are being tested in trial NCT01364740?
The interventions under investigation include: PMP-300E (DEVICE), In-lab PSG (DEVICE).
Who is sponsoring clinical trial NCT01364740?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01364740 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
RECRUITING · Phase 3
-
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
ACTIVE NOT RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
ACTIVE NOT RECRUITING · Phase 3
-
Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea
ACTIVE NOT RECRUITING · Phase 3
-
Effect of Heated Humidity With Thermosmart™ Compared to an Intranasal Steroid in Improving Compliance and Nasal Symptoms in Patients Using Continuous Positive Airway Pressure
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.